Save 20% on Press Releases and More with NNW Prime! Click to View Details
ThursdayJun 03, 2021 10:03 am

NetworkNewsBreaks – Smith Micro Software Inc. (NASDAQ: SMSI) Announces Close of $65.2M Follow-On Offering

Smith Micro Software (NASDAQ: SMSI), a software development company that sells proven solutions to wireless carriers and cable MSOs, has closed on its follow-on underwritten public offering. The offering was comprised of 9,520,787 shares of SMSI common stock. The company announced that the offering resulted in an estimated $65.2 million gross proceeds for the company before discounts, commissions and other required expenses. In the announcement, the company noted that it granted a 30-day option to purchase additional shares to underwriters of the offering; that option allows for the purchase of an additional 1,428,118 shares of the company’s common stock. Smith…

Continue Reading

ThursdayJun 03, 2021 10:00 am

NetworkNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) to Participate at Upcoming LD Micro Invitational XI

Cybin (NEO: CYBN) (OTCQB: CLXPF) CEO Doug Drysdale will be participating at the 2021 LD Micro Invitational XI. The invitational will be held Thursday, June 10. As part of his participation, Drysdale will be presenting a live webcast featuring Cybin, a biotechnology company focused on progressing psychedelic therapeutics. Drysdale’s presentation is scheduled to begin at 3:30 p.m. ET. Interested individuals can register to view the Cybin presentation via the webcast. To view the presentation, visit https://nnw.fm/LfZUc To view the full press release, visit https://nnw.fm/JVL3S About Cybin Inc. Cybin is a leading biotechnology company focused on progressing psychedelic therapeutics for mental…

Continue Reading

ThursdayJun 03, 2021 9:57 am

NetworkNewsBreaks – First Energy Metals Ltd. (CSE: FE) (OTCQB: FEMFF) Announces Closing of Private Placement

First Energy Metals (CSE: FE) (OTCQB: FEMFF), a publicly traded Canadian mineral exploration company, today announced that it has closed a non-brokered private placement for aggregate gross proceeds of $1,000,000. According to the update, the offering consisted of the sale of $771,299.76 flow-through units ("FT units") by way of issuing 2,003,376 shares at $0.385 per FT unit and the sale of $228,700.24 hard dollar units ("HD units ") by way of issuing 682,687 shares at $0.335 per HD unit. Final closing of the transaction and private placement is subject to obtaining all standard regulatory approvals, including from the CSE. All securities…

Continue Reading

ThursdayJun 03, 2021 9:39 am

NetworkNewsBreaks – Trident Acquisitions Corp. (NASDAQ: TDAC) Announces NASDAQ Notification of Delayed Filing of Quarterly Report

Trident Acquisitions (NASDAQ: TDAC, TDACU, TDACW) announced that it had received a standard notice last month from the listing qualifications staff of the Nasdaq Stock Market LLC. The notice stated that TDAC is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires companies to file all required periodic financial reports with the Securities Exchange Commission (“SEC”) in a timely manner. TDAC was notified that the company hadn’t filed its quarterly report for the period ending March 31, 2021. The company also noted that in April, the SEC issued a statement providing guidance for all SPAC-related companies regarding the accounting and…

Continue Reading

WednesdayJun 02, 2021 1:39 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Nears Dosing of Phase 2 Patients with Standout Anthracycline Therapy

CNS Pharmaceuticals (NASDAQ: CNSP) is focused on producing a treatment that improves on the effectiveness of established chemotherapy drug lomustine in increasing overall survival rates of glioblastoma multiforme (“GBM”) patients. GBM is an illness that is nearly 100% fatal in patients just over a year after diagnosis. CNS Pharmaceuticals’ lead drug candidate, Berubicin, has been granted investigational new drug (“IND”) status after promising findings. “Berubicin is a standout anthracycline therapy because of its novel apparent ability to cross the blood-brain barrier to combat neurological tumors. The drug was the subject of a Phase I trial some 15 years ago in…

Continue Reading

WednesdayJun 02, 2021 1:30 pm

NetworkNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Building Strong Commercial Pipeline for Unique PeDAL(TM) Platform

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, continues to create value for a growing customer base through its subsidiaries. Researchers from one such subsidiary, Helomics, recently completed key sequencing milestones for ovarian cancer to help build its AI-driven models of the disease. “We are building a strong commercial pipeline for our unique Patient-cEntric Discovery by Active Learning (PeDAL)(TM), which we launched at the beginning of 2021,” POAI CEO J. Melville Engle was quoted in a recent article. “PeDAL brings together the key Helomics assets of real-world longitudinal data…

Continue Reading

WednesdayJun 02, 2021 12:58 pm

NetworkNewsBreaks – Perpetual Industries Inc. (PRPI) Featured in Video Interview as Incubator of Innovation, Bringing Bright Ideas to Life

Perpetual Industries’ (OTC: PRPI) CEO Brent Bedford was featured in a recent video interview where he provided an overview of PRPI’s business strategy and a closer look at two projects the company is involved in. “PRPI is designed to be an incubator for the development of innovative, energy-efficient technologies aimed at commercializing products that have the potential to impact and advance a wide range of industries on a global scale,” reads a recent article discussing the company. “Everybody knows somebody that is a crazy inventor out there, right?” said Bedford during the video interview, now available on the company’s YouTube…

Continue Reading

WednesdayJun 02, 2021 12:22 pm

NetworkNewsBreaks – Cognos Therapeutics Corp. Signs Agreement to Work with Maxim Group LLC for Investment Banking, Financial Advisory Services

Cognos Therapeutics Corp., an advanced medical device company focused on creating unique technologies to radically advance the diagnosis and treatment of neuropathic diseases, has signed a letter of engagement with Maxim Group LLC. According to the agreement, Maxim will provide financial advisory and investment banking services to Cognos; the services will also include support in identifying and evaluating merger and acquisition opportunities. “We are incredibly pleased to launch this relationship with Maxim,” said Cognos CEO Frank Adell in the press release. “We believe Maxim can assist us in pursuing strategic growth and in building long-term value for our shareholders. . .…

Continue Reading

WednesdayJun 02, 2021 12:09 pm

NetworkNewsBreaks – FingerMotion Inc. (FNGR) Releases Financial Results for FYE 2021

FingerMotion (OTCQX: FNGR), a mobile services and data company, has released its financial results for the fiscal year ending Feb. 28, 2021. A highlight of the report was record annual revenue of $16.68 million, which includes the company’s SMS (“SMS”) & MMS (“MMS”) and telecommunications products and services. That total represents an estimated 82% increase from FYE 2020. Other financial numbers worth noting include annual growth in SMS & MMS business revenue of $6.13 million, or 84% compared to the same period the year before; annual growth in telecommunications products and services business revenue of $1.39 million, or a 76%…

Continue Reading

WednesdayJun 02, 2021 12:07 pm

NetworkNewsBreaks – Finovate Announces Deadline to Nominate Companies and Individuals Driving Fintech Innovation, New Ideas

Finovate, a leading fintech event series and digital engagement platform, has announced the June 11 nomination deadline for companies looking to take part in the 2021 edition of the Finovate Awards. The awards recognize companies driving fintech innovation forward and individuals bringing new ideas to life. Leading banks, fintech firms, accelerators, innovators, and executives will compete in 25 different categories that represent the multitude of ways technology is revolutionizing the financial ecosystem. “It is always important to recognize the dedication and effort that goes into bringing successful fintech solutions to the market, but it’s especially vital this year,” said Greg…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000